USDM video
Watch USDM’s American Biomanufacturing Summit presentation on practical AI adoption, governance, and validation for regulated life sciences operations.
Best next step
Watch the short overview, then use the links below to keep moving: explore the related capability, browse more resources, or start a conversation with USDM.
Talk with USDMTrouble with the embedded player? Open the Wistia-hosted video
Who should watch
Biomanufacturing, quality, validation, IT, and operations leaders evaluating how AI can be adopted in regulated environments without compromising control, traceability, or inspection readiness.
Overview
This presentation discusses how life sciences organizations can approach AI in regulated operations with practical governance, validation thinking, workflow alignment, and business-value discipline rather than disconnected experimentation.
What to take from it
Understand how AI adoption in biomanufacturing and regulated life sciences requires clear intended use, risk controls, and accountable operating models.
Learn why validation, data quality, human oversight, and evidence generation need to be considered early as teams move from pilots to practical deployment.
Identify ways to connect AI initiatives to real workflow needs, compliance visibility, process consistency, and measurable business outcomes.
Keep going
Explore how USDM helps regulated teams move AI from strategy and pilots into governed, practical deployment.
Learn MoreSee how governed agents can support quality, regulatory, clinical, manufacturing, and corporate life sciences workflows.
Learn MoreStart a conversation about AI governance, validation strategy, biomanufacturing workflows, or regulated AI adoption.
Let's Talk